pharma-话题@MedSci

#pharma#

608篇内容 | 2508人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908567, encodeId=64aa190856e3c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, objectType=article, longId=186097, objectId=245d18609efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245d18609efa, replyNumber=0, likeNumber=80, createdTime=2020-03-05, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245d18609efa, moduleTitle=Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245d18609efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908564, encodeId=37741908564fd, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, objectType=article, longId=181662, objectId=2258181662f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2258181662f7, replyNumber=0, likeNumber=51, createdTime=2020-05-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2258181662f7, moduleTitle=Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2258181662f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908560, encodeId=6b811908560a2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, objectType=article, longId=177350, objectId=81311e7350b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81311e7350b0, replyNumber=0, likeNumber=74, createdTime=2019-10-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81311e7350b0, moduleTitle=Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81311e7350b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908562, encodeId=ab5819085624f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=MGB Biopharma宣布其速效强效抗生素MGB-BP-3治疗艰难梭菌相关性腹泻的IIa期临床数据, objectType=article, longId=181138, objectId=375618113829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=375618113829, replyNumber=0, likeNumber=49, createdTime=2019-11-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=375618113829, moduleTitle=MGB Biopharma宣布其速效强效抗生素MGB-BP-3治疗艰难梭菌相关性腹泻的IIa期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=375618113829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908572, encodeId=f83719085e222, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, objectType=article, longId=188697, objectId=625518869e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625518869e6a, replyNumber=0, likeNumber=67, createdTime=2020-11-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625518869e6a, moduleTitle=Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625518869e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908569, encodeId=08501908569fc, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Verona Pharma公布ensifentrine作为慢性阻塞性肺病（COPD）维持治疗的II期临床结果, objectType=article, longId=188170, objectId=28501881e0e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28501881e0e2, replyNumber=0, likeNumber=65, createdTime=2020-10-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28501881e0e2, moduleTitle=Verona Pharma公布ensifentrine作为慢性阻塞性肺病（COPD）维持治疗的II期临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28501881e0e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908553, encodeId=2b2e1908553a6, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Sunstone为芬兰女性健康公司Forendo Pharma投资500万欧元，用于资助子宫内膜异位症的临床研究, objectType=article, longId=175959, objectId=f06e1e5959ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f06e1e5959ef, replyNumber=0, likeNumber=66, createdTime=2019-08-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f06e1e5959ef, moduleTitle=Sunstone为芬兰女性健康公司Forendo Pharma投资500万欧元，用于资助子宫内膜异位症的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f06e1e5959ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908565, encodeId=64fb1908565ff, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染, objectType=article, longId=182393, objectId=3c1f1823939d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c1f1823939d, replyNumber=0, likeNumber=64, createdTime=2019-11-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c1f1823939d, moduleTitle=RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c1f1823939d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908548, encodeId=eca2190854868, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, objectType=article, longId=174474, objectId=94081e4474dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94081e4474dd, replyNumber=0, likeNumber=51, createdTime=2019-09-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94081e4474dd, moduleTitle=Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94081e4474dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908541, encodeId=f9bf190854158, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：白藜芦醇苷通过激活BMP2-Wnt /β-catenin信号通路促进人骨髓间充质干细胞的成骨分化, objectType=article, longId=165168, objectId=afce1651681c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afce1651681c, replyNumber=0, likeNumber=59, createdTime=2019-07-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afce1651681c, moduleTitle=Biomed Pharmacother：白藜芦醇苷通过激活BMP2-Wnt /β-catenin信号通路促进人骨髓间充质干细胞的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afce1651681c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908538, encodeId=801d19085387a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移, objectType=article, longId=164881, objectId=b51e164881ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b51e164881ee, replyNumber=0, likeNumber=50, createdTime=2019-08-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b51e164881ee, moduleTitle=Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b51e164881ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908524, encodeId=0827190852449, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据, objectType=article, longId=161013, objectId=3a4b1610135a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a4b1610135a, replyNumber=0, likeNumber=0, createdTime=2019-07-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a4b1610135a, moduleTitle=2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a4b1610135a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908566, encodeId=a272190856612, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点, objectType=article, longId=184948, objectId=7e421849487b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e421849487b, replyNumber=0, likeNumber=71, createdTime=2020-10-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e421849487b, moduleTitle=LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e421849487b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908529, encodeId=66d0190852950, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, objectType=article, longId=161805, objectId=b36616180596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b36616180596, replyNumber=0, likeNumber=61, createdTime=2019-12-31, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b36616180596, moduleTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b36616180596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908568, encodeId=6032190856851, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表, objectType=article, longId=186098, objectId=1cee18609806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cee18609806, replyNumber=0, likeNumber=0, createdTime=2020-03-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cee18609806, moduleTitle=Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cee18609806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908552, encodeId=9393190855247, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=FDA指控Strides Pharma Science印度工厂存在"重大违规行为", objectType=article, longId=175748, objectId=0b8f1e574862, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b8f1e574862, replyNumber=0, likeNumber=0, createdTime=2020-05-19, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b8f1e574862, moduleTitle=FDA指控Strides Pharma Science印度工厂存在"重大违规行为", moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b8f1e574862)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908549, encodeId=b923190854991, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Exp Pharmacol Physiol：淫羊藿苷能够抑制组胺诱导的鼻粘膜上皮细胞炎症细胞因子和粘蛋白的表达, objectType=article, longId=174686, objectId=2b691e46865b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b691e46865b, replyNumber=0, likeNumber=88, createdTime=2020-05-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b691e46865b, moduleTitle=Clin Exp Pharmacol Physiol：淫羊藿苷能够抑制组胺诱导的鼻粘膜上皮细胞炎症细胞因子和粘蛋白的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b691e46865b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908539, encodeId=18a019085394c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, objectType=article, longId=164907, objectId=fe4216490eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4216490eae, replyNumber=0, likeNumber=95, createdTime=2019-07-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4216490eae, moduleTitle=Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4216490eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908544, encodeId=03a71908544cb, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：过敏性鼻炎中桔皮素能够促进T细胞分化, objectType=article, longId=166157, objectId=903616615e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=903616615e66, replyNumber=0, likeNumber=73, createdTime=2019-09-12, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=903616615e66, moduleTitle=Int Immunopharmacol：过敏性鼻炎中桔皮素能够促进T细胞分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=903616615e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908517, encodeId=f221190851e8d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展, objectType=article, longId=159563, objectId=7dc9159563bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dc9159563bd, replyNumber=0, likeNumber=67, createdTime=2019-07-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dc9159563bd, moduleTitle=Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dc9159563bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Frontier in Pharmacology：HIV感染者使用LPV/r二线治疗的长期、大规模、多中心、真实世界研究结果发布

2020-03-05

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol: 叶酸补充可降低高血压伴糖尿病患者的视网膜动脉粥样硬化风险

2020-05-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：白藜芦醇苷可用于治疗糖皮质激素诱导的骨坏死

2019-10-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

MGB Biopharma宣布其速效强效抗生素MGB-BP-3治疗艰难梭菌相关性腹泻的IIa期临床数据

2019-11-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmaceutics：脂质体槲皮素和没食子酸联合局部治疗阴道念珠菌感染

2020-11-24

chentianping (审核中...)

前往app查看评论内容

#pharma#

Verona Pharma公布ensifentrine作为慢性阻塞性肺病（COPD）维持治疗的II期临床结果

2020-10-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

Sunstone为芬兰女性健康公司Forendo Pharma投资500万欧元，用于资助子宫内膜异位症的临床研究

2019-08-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

RedHill Biopharma宣布FDA批准Talicia用于治疗成人幽门螺旋杆菌感染

2019-11-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：长非编码RNA SNHG16对miR-140-5p具有海绵促进人视网膜母细胞瘤发生发展

2019-09-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：白藜芦醇苷通过激活BMP2-Wnt /β-catenin信号通路促进人骨髓间充质干细胞的成骨分化

2019-07-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：绿蜂胶提取物促进骨髓基质细胞的体外增殖，分化和迁移

2019-08-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

2019年美国皮肤病学会会议：Principia Biopharma将宣布疱疮寻常型试验的全新数据

2019-07-21

chentianping (审核中...)

前往app查看评论内容

#pharma#

LEO pharma的IL-13单抗在III期特应性皮炎临床研究中达到实验终点

2020-10-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号

2019-12-31

chentianping (审核中...)

前往app查看评论内容

#pharma#

Frontiers in Pharmacology：LPV/r一线治疗HIV感染研究结果发表

2020-03-26

chentianping (审核中...)

前往app查看评论内容

#pharma#

FDA指控Strides Pharma Science印度工厂存在"重大违规行为"

2020-05-19

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Exp Pharmacol Physiol：淫羊藿苷能够抑制组胺诱导的鼻粘膜上皮细胞炎症细胞因子和粘蛋白的表达

2020-05-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Variant Pharmaceuticals的新型炎性小体单抗获得全球**许可

2019-07-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：过敏性鼻炎中桔皮素能够促进T细胞分化

2019-09-12

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：MicroRNA-9-5p通过靶向Wnt3a抑制骨生成和促进脂肪生成，促进骨质疏松症的发展

2019-07-23

科室
- - 订阅+
  - 更多科室
工具
服务